Optipharm Co (XKRX:153710) FCF Margin % : -9.85% (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Optipharm Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Optipharm Co's Free Cash Flow for the three months ended in Sep. 2024 was ₩-472 Mil. Optipharm Co's Revenue for the three months ended in Sep. 2024 was ₩4,786 Mil. Therefore, Optipharm Co's FCF Margin % for the quarter that ended in Sep. 2024 was -9.85%.

As of today, Optipharm Co's current FCF Yield % is -2.31%.

The historical rank and industry rank for Optipharm Co's FCF Margin % or its related term are showing as below:

XKRX:153710' s FCF Margin % Range Over the Past 10 Years
Min: -43.73 Med: -13.46 Max: 6.6
Current: -8.54

During the past 11 years, the highest FCF Margin % of Optipharm Co was 6.60%. The lowest was -43.73%. And the median was -13.46%.

XKRX:153710's FCF Margin % is ranked worse than
53.24% of 216 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.655 vs XKRX:153710: -8.54

Optipharm Co FCF Margin % Historical Data

The historical data trend for Optipharm Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optipharm Co FCF Margin % Chart

Optipharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-2.26

-19.71

-19.12

-43.73

-19.92

Optipharm Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-5.69	1.11	-31.36	2.71	-9.85

Competitive Comparison of Optipharm Co's FCF Margin %

For the Diagnostics & Research subindustry, Optipharm Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optipharm Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Optipharm Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Optipharm Co's FCF Margin % falls into.

Optipharm Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Optipharm Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3459.893	/	17372.568
	=	-19.92 %

Optipharm Co's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-471.624	/	4786.217
	=	-9.85 %

Optipharm Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Optipharm Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Optipharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Optipharm Co Ltd (XKRX:153710) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6, 63 Osong, Hwaseong-eup, Heungduk-gu, Chungcheongbuk-do, Cheongju, KOR

Website

http://www.optipharm.co.kr

Optipharm Co Ltd is engaged in developing cell therapy products through animal stem cells, developing high value-added protein drugs using bio-reactors, selecting antibiotic/antiviral components and developing products. Its diagnosis division includes human diagnosis and animal diagnosis that focuses on the development of molecular diagnostics for a variety of diseases.

Optipharm Co Headlines

No Headlines